These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23425057)

  • 1. Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis.
    Koo JK; Kim JH; Choi YJ; Lee CI; Yang JH; Yoon HY; Choi HJ; Ko SY; Choe WH; Kwon SY; Lee CH
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1209-16. PubMed ID: 23425057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
    Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
    Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis.
    Kim JW; Kim JH; Choe WH; Kwon SY; Yoo BC
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984593
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].
    Valenzuela Granados V; Salazar-Quiñones M; Cheng-Zárate L; Malpica-Castillo A; Huerta Mercado J; Ticse R
    Rev Gastroenterol Peru; 2015; 35(4):307-12. PubMed ID: 26802883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea.
    Kim JH; Cho YJ; Choe WH; Kwon SY; Yoo BC
    Korean J Intern Med; 2024 Mar; 39(2):248-260. PubMed ID: 38296843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis.
    Antunes AG; Teixeira C; Vaz AM; Martins C; Queirós P; Alves A; Velasco F; Peixe B; Oliveira AP; Guerreiro H
    Gastroenterol Hepatol; 2017 Apr; 40(4):276-285. PubMed ID: 28222896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of CTP, MELD, and MELD-Na scores for predicting short term mortality in patients with liver cirrhosis].
    Kim SY; Yim HJ; Lee J; Lee BJ; Kim DI; Jung SW; Han WS; Lee JS; Koo JS; Seo YS; Yeon JE; Lee HS; Lee SW; Um SH; Byun KS; Choi JH; Ryu HS
    Korean J Gastroenterol; 2007 Aug; 50(2):92-100. PubMed ID: 17928752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis.
    Lee M; Lee JH; Oh S; Jang Y; Lee W; Lee HJ; Yoo JJ; Choi WM; Cho YY; Cho Y; Lee DH; Lee YB; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Lee HS
    Liver Int; 2015 Jan; 35(1):46-57. PubMed ID: 25203221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohort.
    Lim J; Kim JH; Kim SE; Han SK; Kim TH; Yim HJ; Jung YK; Song DS; Yoon EL; Kim HY; Kang SH; Chang Y; Yoo JJ; Lee SW; Park JG; Park JW; Jeong SW; Suk KT; Kim MY; Kim SG; Kim W; Jang JY; Yang JM; Kim DJ;
    J Gastroenterol Hepatol; 2024 Sep; 39(9):1932-1938. PubMed ID: 38720448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of model for end-stage liver disease score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital].
    Song CS; Yoon MY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2011 Jun; 57(6):340-5. PubMed ID: 21694485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
    Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department.
    Wan SZ; Nie Y; Zhang Y; Liu C; Zhu X
    Dis Markers; 2020; 2020():5193028. PubMed ID: 32148566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure.
    Peng Y; Qi X; Tang S; Deng H; Li J; Ning Z; Dai J; Hou F; Zhao J; Wang R; Guo X
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):971-80. PubMed ID: 27070325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease.
    Remmler J; Schneider C; Treuner-Kaueroff T; Bartels M; Seehofer D; Scholz M; Berg T; Kaiser T
    Clin Gastroenterol Hepatol; 2018 May; 16(5):730-737. PubMed ID: 28919544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model predicting short-term mortality in patients with advanced liver cirrhosis and concomitant infection.
    Li Y; Chaiteerakij R; Kwon JH; Jang JW; Lee HL; Cha S; Ding XW; Thongprayoon C; Ha FS; Nie CY; Zhang Q; Yang Z; Giama NH; Roberts LR; Han T
    Medicine (Baltimore); 2018 Oct; 97(41):e12758. PubMed ID: 30313084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Recalibrated Four-Category Child-Pugh Score Performs Better than the Original Child-Pugh and MELD Scores in Predicting In-Hospital Mortality in Decompensated Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: a Real-World Cohort Analysis.
    Krige J; Spence RT; Jonas E; Hoogerboord M; Ellsmere J
    World J Surg; 2020 Jan; 44(1):241-246. PubMed ID: 31583458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.